The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence of fractures among men with stage IV prostate cancer (S4PC).
Abdulla M. Abdulhalim
No relevant relationships to disclose
Ebere Onukwugha
Consultant or Advisory Role - Janssen
Honoraria - IMS Health
Research Funding - Amgen; Bayer
Corinne Woods
No relevant relationships to disclose
Yi Qian
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Jorge Arellano
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Arun Balakumaran
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
C. Daniel Mullins
Consultant or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Novartis; Novo Nordisk; Pfizer
Honoraria - Celgene
Research Funding - Bayer; Pfizer
Arif Hussain
Research Funding - Amgen